Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: A meta-analysis based on 17 case-control studies

Molecular Biology Reports

Volumn 38, Issue 7, 2011, Pages 4461-4467

  Mi, Yuan Yuan ^a   Yu, Qian Qian ^a   Xu, Bin ^a   Zhang, Li Feng ^a   Min, Zhi Chao ^a   Hua, Li Xin ^a   Feng, Ning Han ^a   Yao, Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; IFN ; Meta analysis; Polymorphism

Indexed keywords

GAMMA INTERFERON;

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EMBASE; ETHNIC DIFFERENCE; GAMMA INTERFERON GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MEDLINE; MELANOMA; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 80052433454     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0575-3     Document Type: Article

References (41)

1. SH Song JK Lee NW Lee HS Saw JS Kang KW Lee 2008 Interferon-gamma (IFN-gamma): a possible prognostic marker for clearance of high-risk human papillomavirus (HPV) Gynecol Oncol 108 543 548 18164379 10.1016/j.ygyno.2007.11. 006 1:CAS:528:DC%2BD1cXitlCjtr8%3D
2. GR Stark IM Kerr BR Williams RH Silverman RD Schreiber 1998 How cells respond to interferons Annu Rev Biochem 67 227 264 9759489 10.1146/annurev. biochem.67.1.227 1:CAS:528:DyaK1cXlsFOmsLo%3D
3. YE Chin M Kitagawa WC Su ZH You YXY Iwamoto 1996 Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21WAF1/CIP1 mediated by STAT1 Science 272 719 722 8614832 10.1126/science.272.5262.719 1:CAS:528: DyaK28Xislamtrs%3D
4. JF Bromberg CM Horvath Z Wen RD Schreiber JE Darnell Jr 1996 Transcriptionally active Stat1 is required for the anti-proliferative effects of both interferon-α and interferon-γ Proc Natl Acad Sci USA 93 7673 7678 8755534 10.1073/pnas.93.15.7673 1:CAS:528:DyaK28XksFSrsLc%3D
5. M Mandal D Bandyopadhyay TM Goepfert R Kumar 1998 Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK) Oncogene 16 217 225 9464540 10.1038/sj.onc.1201529 1:CAS:528: DyaK1cXmsV2lsw%3D%3D
6. A Buard C Vivo I Monnet C Boutin Y Pilatte MC Jaurand 1998 Human malignant mesothelioma cell growth: activation of janus kinase 2 and signal transducer and activator of transcription 1α for inhibition by interferon-γ Cancer Res 58 840 847 9485044 1:CAS:528:DyaK1cXht1amsrw%3D
7. B Chen L He VH Savell JJ Jenkins DM Parham 2000 Inhibition of the interferon-γ/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region Cancer Res 60 3290 3298 10866323 1:CAS:528:DC%2BD3cXktlyku70%3D
8. D Hanahan J Folkman 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 353 364 8756718 10.1016/S0092-8674(00)80108-7 1:CAS:528:DyaK28XltVSks7s%3D
9. J Folkman 1999 Angiogenic zip code Nat Biotechnol 17 749 10429233 10.1038/11676 1:CAS:528:DyaK1MXmtFGjtb8%3D
10. J Calvo N Martínez A Etxagibel S Calleja C Sáez-torres M Sedeño R Julià J Muncunill N Matamoros A Gayà 2002 Allelic frequencies of polymorphic variants of cytokine genes (IL1A, IL1B, IL1RN, IL6, IL10, IL12p40, and IFNG) in a Spanish population Inmunologia 21 2 76 86
11. V Pravica A Asderakis C Perrey A Hajeer PJ Sinnott IV Hutchison 1999 In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-γ gene Eur J Immunogenet 26 1 3 10068907 10.1046/j.1365-2370. 1999.00122.x 1:CAS:528:DyaK1MXhvVOkt74%3D
12. V Pravica C Perrey A Stevens J-H Lee IV Hutchinson 2000 A single nucleotide polymorphism in the first intron of the human IFN-γ gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production Hum Immunol 61 863 866 11053629 10.1016/S0198-8859(00) 00167-1 1:CAS:528:DC%2BD3cXosVWlu7s%3D
13. GI Matos J Covas Cde C Bittar Rde A Gomes-Silva F Marques VC Maniero VS Amato MP Oliveira-Neto S Mattos Mda C Pirmez EP Sampaio MO Moraes AM Da-Cruz 2007 IFNγ +874 T/A polymorphism is not associated with American tegumentary leishmaniasis susceptibility but can influence Leishmania induced IFN-gamma production BMC Infect Dis 7 33 17456233 10.1186/1471-2334-7-33
14. CM Horvath 2004 The Jak-STAT pathway stimulated by interferon gamma Sci STKE 260 tr8 10.1126/stke.2602004tr8
15. DJ Gough DE Levy RW Johnstone CJ Clarke 2008 IFN gamma signaling-does it mean JAK-STAT? Cytokine Growth Factor Rev 19 383 394 18929502 10.1016/j.cytogfr.2008.08.004 1:CAS:528:DC%2BD1cXhsVCmsLvL
16. FP Schena G Cerullo DD Torres F Scolari M Foramitti A Amoroso D Pirulli J Floege PR Mertens K Zerres E Alexopoulos D Kirmizis L Zelante L Bisceglia 2006 Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study Eur J Hum Genet 14 488 496 16493441 10.1038/sj.ejhg.5201591 1:CAS:528:DC%2BD28XivVyktbw%3D
17. L Scola M Vaglica A Crivello L Palmeri GI Forte MC Macaluso A Giacalone L Di Noto A Bongiovanni C Raimondi A Accardo R Verna G Candore C Caruso D Lio S Palmeri 2006 Cytokine gene polymorphisms and breast cancer susceptibility Ann NY Acad Sci 1089 104 109 17261759 10.1196/annals.1386.017 1:CAS:528: DC%2BD2sXhsFertL8%3D
18. E Kamali-Sarvestani A Merat AR Talei 2005 Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer Cancer Lett 223 113 119 15890243 10.1016/j.canlet.2004.09.025 1:CAS:528:DC%2BD2MXktVOmsr0%3D
19. G Gonullu B Basturk T Evrensel B Oral A Gozkaman O Manavoglu 2007 Association of breast cancer and cytokine gene polymorphism in Turkish women Saudi Med J 28 1728 1733 17965799
20. R Gangwar S Pandey RD Mittal 2009 Association of interferon-gamma +874 A polymorphism with the risk of developing cervical cancer in north-Indian population BJOG 116 1671 1677 19681846 10.1111/j.1471-0528.2009.02307.x 1:CAS:528:DC%2BD1MXhsVOhu7%2FM
21. MK Kordi Tamandani RC Sobti M Shekari M Mukesh V Suri 2008 Expression and polymorphism of IFN-gamma gene in patients with cervical cancer Exp Oncol 30 224 229 18806746 1:STN:280:DC%2BD1cnhslWmtg%3D%3D
22. VA Govan HR Carrara JA Sachs M Hoffman GA Stanczuk AL Williamson 2003 Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer J Carcinog 2 3 12809559 10.1186/1477-3163-2-3
23. PN Nikolova GP Pawelec SM Mihailova 2007 Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population Cancer Immunol Immunother 56 371 379 16835788 10.1007/s00262-006-0193-z 1:CAS:528: DC%2BD2sXot1Sm
24. WM Howell SJ Turner JM Theaker AC Bateman 2003 Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma Eur J Immunogenet 30 409 414 14675394 10.1111/j.1365-2370. 2003.00425.x 1:CAS:528:DC%2BD2cXmt1Sksw%3D%3D
25. K Farhat E Hassen S Gabbouj N Bouaouina L Chouchane 2008 Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma Int J Immunogenet 35 197 205 18312596 10.1111/j.1744-313X.2008.00752.x 1:CAS:528:DC%2BD1cXntlansrY%3D
26. M Colakogullari E Ulukaya A Yilmaztepe Oral F Aymak B Basturk A Ursavas HB Oral 2008 The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients Cell Biochem Funct 26 283 290 17654453 10.1002/cbf.1419 1:CAS:528:DC%2BD1cXlsF2htrg%3D
27. ZP Nearman M Wlodarski AM Jankowska E Howe Y Narvaez E Ball JP Maciejewski 2007 Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias Br J Haematol 136 237 248 17156396 10.1111/j.1365-2141.2006.06429.x 1:CAS:528:DC%2BD2sXislSnsb4%3D
28. B Baştürk I Yavaşçaoǧlu H Vuruşkan G Göral B Oktay HB Oral 2005 Cytokine gene polymorphisms as potential risk and protective factors in renal cell carcinoma Cytokine 30 41 45 15784411 10.1016/j.cyto.2004.10.016
29. K Migita S Miyazoe Y Maeda M Daikoku S Abiru T Ueki K Yano S Nagaoka T Matsumoto K Nakao K Hamasaki H Yatsuhashi H Ishibashi K Eguchi 2005 Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma J Hepatol 42 505 510 15763337 10.1016/j.jhep.2004.11.026 1:CAS:528:DC%2BD2MXitFyru78%3D
30. DK Ahirwar A Agrahari A Mandhani RD Mittal 2009 Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy Biomarkers 14 213 218 19489682 10.1080/13547500902818246 1:CAS:528:DC%2BD1MXmslChtrY%3D
31. BA Talseth C Meldrum J Suchy G Kurzawski J Lubinski RJ Scott 2007 Lack of association between genetic polymorphisms in cytokine genes and disease expression in patients with hereditary non-polyposis colorectal cancer Scand J Gastroenterol 42 628 632 17454884 10.1080/00365520601106699 1:CAS:528: DC%2BD2sXmt12qsbs%3D
32. R Talar-Wojnarowska A Gasiorowska B Smolarz H Romanowicz-Makowska A Kulig E Malecka-Panas 2009 Tumor necrosis factor alpha and interferon gamma genes polymorphisms and serum levels in pancreatic adenocarcinoma Neoplasma 56 56 62 19152246 10.4149/neo-2009-01-56 1:CAS:528:DC%2BD1MXit1Cnt7Y%3D
33. R Der Simonian N Laird 1986 Meta-analysis in clinical trials Control Clin Trials 7 177 188 10.1016/0197-2456(86)90046-2
34. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 13655060 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D
35. M Egger G Davey Smith M Schneider C Minder 1997 Bias in metaanalysis detected by a simple, graphical test BMJ 315 629 634 9310563 1:STN:280:DyaK2svls1KjtA%3D%3D
36. K Schroder PJ Hertzog T Ravasi DA Hume 2004 Interferon-c an overview of signals mechanisms and functions J Leukoc Biol 75 163 189 14525967 10.1189/jlb.0603252 1:CAS:528:DC%2BD2cXhsFKntrk%3D
37. E Tartour A Gey X Sastre-Garau I Lombard Surin V Mosseri WH Fridman 1998 Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas J Natl Cancer Inst 90 287 294 9486814 10.1093/jnci/90.4.287 1:STN:280:DyaK1c7ks1aiuw%3D%3D
38. A Gey P Kumari A Sambandam F Lecuru L Cassard C Badoual C Fridman B Nagarajan WH Fridman E Tartour 2003 Identification and characterization of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFN gamma) and Type 2 (IL-4) cytokine mRNA expression Eur J Cancer 39 595 603 12628838 10.1016/S0959-8049(02)00839-0 1:CAS:528: DC%2BD3sXhvFGku70%3D
39. HW Tso WK Ip WP Chong CM Tam AK Chiang YL Lau 2005 Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese Genes Immun 6 358 363 15815688 10.1038/sj.gene.6364189 1:CAS:528: DC%2BD2MXks1Gmtro%3D
40. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D
41. Q Wei L Cheng CI Amos LE Wang Z Guo WK Hong MR Spitz 2000 Repair of tobacco carcinogen induced DNA adducts and lung cancer risk: a molecular epidemiologic study J Natl Cancer Inst 92 1764 1772 11058619 10.1093/jnci/92.6.440 1:CAS:528:DC%2BD3cXot1SltLs%3D